Quest Pharmatech's market cap is currently ―. The company's EPS TTM is C$-0.131; its P/E ratio is -0.25; Quest Pharmatech is scheduled to report earnings on May 28, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22
Income Statement	-
Total Revenue	-	C$ 1.82K	C$ 13.90K	-	-
Gross Profit	-	C$ 1.82K	C$ 13.90K	-	-
EBIT	C$ -2.51M	C$ -9.81M	C$ -5.17M	C$ -4.75M	C$ -905.42K
EBITDA	C$ -2.51M	C$ -9.81M	C$ -5.17M	C$ -4.75M	C$ -908.48K
Net Income Common Stockholders	C$ -2.51M	C$ -9.82M	C$ -5.17M	C$ -4.76M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 93.96K	C$ 101.46K	C$ 90.65K	C$ 374.66K	C$ 0.00
Total Assets	C$ 67.34M	C$ 69.72M	C$ 79.08M	C$ 84.36M	-
Total Debt	C$ 1.00M	C$ 1.00M	C$ 800.00K	C$ 0.00	C$ 0.00
Net Debt	C$ 906.04K	C$ 898.54K	C$ 709.35K	C$ -374.66K	C$ 0.00
Total Liabilities	C$ 1.16M	C$ 1.03M	C$ 997.36K	C$ 1.11M	-
Stockholders Equity	C$ 66.17M	C$ 68.68M	C$ 78.08M	C$ 83.25M	C$ 0.00
Cash Flow	-
Free Cash Flow	C$ -7.50K	C$ -189.19K	C$ -84.01K	C$ -197.04K	C$ 185.60K
Operating Cash Flow	C$ -7.50K	C$ -189.19K	C$ -82.52K	C$ -197.04K	-
Investing Cash Flow	-	-	C$ -1.49K	C$ -1.00	-
Financing Cash Flow	-	C$ 200.00K	C$ -200.00K	C$ 90.00K	-

Currency in CAD

Quest Pharmatech Earnings and Revenue History

Income Statement >

Quest Pharmatech Debt to Assets

Balance Sheet >

Quest Pharmatech Cash Flow

Cash Flow >

Quest Pharmatech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing